Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup

15 Aug 2018

Abstract excerpt

BACKGROUND: Reliable biomarkers of frontotemporal dementia (FTD) are currently lacking. FTD may be associated with chronic immune dysfunction, microglial activation and raised inflammatory markers, particularly in progranulin (GRN) mutation carriers. Levels of soluble triggering receptor expressed on myeloid cells 2 (sTREM2) are elevated in Alzheimer's disease (AD), but they have not been fully explored in FTD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyotrophic Lateral Sclerosis Research
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30111356
DOI: 10.1186/s13195-018-0405-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupPMID 30111356Read ↗

CSF Soluble TREM2 Concentrations Correlate With the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer’s DiseaseSemantic proximity Read ↗

CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia.Semantic proximity Read ↗

Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.Semantic proximity Read ↗

Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimers diseaseSemantic proximity Read ↗

Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury.Semantic proximity Read ↗

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineSemantic proximity Read ↗

APOEε4 attenuates early TREM2-mediated microglial responses and influences disease trajectories in dementia with Lewy bodiesSemantic proximity Read ↗

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.Semantic proximity Read ↗

Longitudinal increase of CSF soluble TREM2 is driven by early aggregation of Aβ42 and associates with slower amyloid deposition and clinical decline in autosomal-dominant Alzheimer’s diseaseSemantic proximity Read ↗

Peripheral sTREM2-related inflammatory activity alterations in early stage Alzheimer’s diseaseSemantic proximity Read ↗

The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.Semantic proximity Read ↗

The <i>MS4A</i> gene cluster is a key regulator of soluble TREM2 and Alzheimer disease riskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.